MIRADOR CAPITAL PARTNERS LP Celldex Therapeutics, Inc. Transaction History

MIRADOR CAPITAL PARTNERS LP portfolio value:

$3.01M
portfolio value

MIRADOR CAPITAL PARTNERS LP quarter portfolio value change:

+4.27%
quarter

Celldex Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +0.71% 760 shares 143K $28.11 107.12K
Q2 2022 share Increase +18.12% 16.32K shares -199K $26.96 106.36K
Q1 2022 share Increase +4.64% 3.99K shares -258K $34.06 90.04K
Q4 2021 share Increase +16.73% 12.33K shares -655K $38.9 86.05K
Q3 2021 share Decrease -6.31% -4.96K shares 1.34M $53.99 73.71K
Q2 2021 share Increase +3.97% 3.00K shares 1.07M $33.44 78.67K
Q1 2021 share Increase +182.91% 48.92K shares 1.09M $20.6 75.67K
Q4 2020 share Increase +5.04% 1.28K shares 91K $17.52 26.74K
Q3 2020 share Increase +33.09% 6.33K shares 129K $14.83 25.46K
Q2 2020 share Increase +68.85% 7.80K shares 222K $13 19.13K
Q1 2020 share Increase 0.00% 11.33K shares 27K $1.66 11.33K